Aurobindo to Start US Units This Year; China Plant Nears Q3 FY26 Break-Even
New Delhi, August 18, 2025 — Aurobindo Pharma said two manufacturing units in the United States are slated to start production within the current fiscal, tightening the company’s supply chain…
NPPA fixes retail prices for 41 drug combinations, including empagliflozin
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 41 drug combinations, including 18 variants of the off-patent diabetes drug empagliflozin, originally developed by German pharmaceutical company…
Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 cr
Lincoln Pharmaceuticals on Thursday reported a net profit of Rs 11.62 crore for the March quarter of 2024-25 and said it is building a portfolio in lifestyle and chronic segments,…









